Ketamine alleviates fear, depression, and suicidal ideation in terminally ill patients

Journal of Palliative Medicine

Volumn 14, Issue 4, 2011, Pages 389-

  Thangathurai, Duraiyah ^a   Mogos, Mariana ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KETAMINE;

ANXIETY DISORDER; DISEASE SEVERITY; DRUG MECHANISM; FEAR; HUMAN; INTENSIVE CARE; LETTER; MAJOR DEPRESSION; SUICIDAL IDEATION; TERMINAL CARE; TERMINALLY ILL PATIENT;

ANALGESICS; DEPRESSION; FEAR; HUMANS; KETAMINE; SUICIDAL IDEATION; TERMINALLY ILL;

EID: 79953847825     PISSN: 10966218     EISSN: None     Source Type: Journal    
DOI: 10.1089/jpm.2010.0499     Document Type: Letter

References (3)

1. Zarate CA Jr, Singh JB, Carlson PJ Brutsche NE, Ameli R, Luckenbaugh DA, Charney DS, Manji HK.: A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 2006;63:856-864 (Pubitemid 44188478)
2. Hirota K, Lambert DJ: Ketamine: its mechanism(s) of action and unusual clinical uses. Br J Anesth 1996;77:441-444. (Pubitemid 26341027)
3. Quevedo J, Comim CM, Gavioli EC: Ketamine induces rapid onset of antidepressant action: Neurophysiological biomark-ers as predictors of effect. Biomarkers Med 2009;3:5-8.